US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Replimune Group Inc.

14.71

-0.0600-0.41%

Post-market: 14.710.00000.00%16:10 EDT

Volume:2.08M

Turnover:30.74M

Market Cap:1.39B

PE:-4.66

High:15.04

Open:14.63

Low:14.11

Close:14.77

52wk High:15.71

52wk Low:1.50

Shares:94.22M

Float Shares:77.49M

Volume Ratio:0.62

T/O Rate:2.68%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.1550

EPS(LYR):-3.3828

ROE:-134.29%

ROA:-51.30%

PB:13.12

PE(LYR):-4.35

Loading ...

Overview Company News Filings

Replimune downgraded to Sell from Buy at H.C. Wainwright

BUZZ-Replimune slumps after FDA drug rejection prompts downgrades

Replimune Shares Decline 58% Premarket After at Least Two Brokerages Downgrade Stock After Advanced Skin Cancer Fails to Win FDA Nod

THOMSON REUTERS

Replimune Group Inc : JP Morgan Cuts to Underweight From Neutral

THOMSON REUTERS

Replimune downgraded to Hold from Buy at Jefferies

BRIEF-Replimune Group Disagrees With FDA About Whether Rp1 BLA Data Set Is Enough To Allow The Medicine To Be Made Available To Advanced Cancer Patients

Replimune says FDA’s CRL for RP1 ‘disappointing’

Replimune says FDA ‘appears to have contradicted their positions’ in CRL

Replimune Group: We Have No Choice but to Eliminate Jobs, Including Substantially Scaling Back Our U.S. Based Manufacturing Operations

THOMSON REUTERS

Replimune: Based on FDA Feedback, Started Ignyte-3 to Satisfy Regulatory Requirement That Confirmatory Study Be Underway for Accelerated Approval

THOMSON REUTERS

Replimune downgraded to Neutral from Overweight at Cantor Fitzgerald

Replimune downgraded to Neutral from Overweight at Piper Sandler

Sector Update: Health Care Stocks Lower Friday Afternoon

MT Newswires Live

Replimune CRL positive for Iovance in near-term, says Chardan

Top Midday Decliners

MT Newswires Live

BRIEF-FDA Says Data Insufficient To Conclude Effectiveness Of Replimune's vusolimogene oderparepvec

Replimune Stock Tumbles After FDA Rejects Skin Cancer Therapy for Second Time -- Barrons.com

Replimune's Biologics License Application for Advanced Cutaneous Melanoma Drug Rejected by FDA

MT Newswires Live

Replimune Group's Drug for Advanced Cutaneous Melanoma Rejected by FDA

MT Newswires Live

Replimune issued Complete Response Letter for RP1 for advanced melanoma

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/REPL/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"REPL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REPL\",,,,,undefined,":{"symbol":"REPL","market":"US","secType":"STK","nameCN":"Replimune Group Inc.","latestPrice":14.71,"timestamp":1787601600000,"preClose":14.77,"halted":0,"volume":2079846,"hourTrading":{"tag":"盘后","latestPrice":14.71,"preClose":14.71,"latestTime":"16:10 EDT","volume":47983,"amount":705829.93,"timestamp":1787602205370,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.004062288422477909,"floatShares":77485633,"shares":94219634,"eps":-3.154987,"marketStatus":"Post-Mkt","change":-0.06,"latestTime":"08-24 16:12:38 EDT","open":14.63,"high":15.04,"low":14.11,"amount":30744273.17277,"amplitude":0.062965,"askPrice":14.71,"askSize":37,"bidPrice":14.6,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-3.154987,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1532059200000,"exchange":"NASDAQ","adjPreClose":14.77,"preHourTrading":{"tag":"盘前","latestPrice":14.52,"preClose":14.77,"latestTime":"09:29 EDT","volume":1660,"amount":24302.77184,"timestamp":1787578199999,"change":-0.25,"changeRate":-0.016926,"amplitude":0.018768},"postHourTrading":{"tag":"盘后","latestPrice":14.71,"preClose":14.71,"latestTime":"16:10 EDT","volume":47983,"amount":705829.93,"timestamp":1787602205370,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.623195,"impliedVol":0.8231,"impliedVolPercentile":0.1116},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REPL\",,,,,undefined,":{"symbol":"REPL","floatShares":77485633,"roa":"-51.30%","roe":"-134.29%","lyrEps":-3.382838,"volumeRatio":0.623195,"shares":94219634,"dividePrice":0,"high":15.04,"amplitude":0.062965,"preClose":14.77,"low":14.11,"week52Low":1.5,"pbRate":"13.12","week52High":15.705,"institutionHeld":0,"latestPrice":14.71,"committee":0.687764,"eps":-3.154987,"divideRate":0,"volume":2079846,"delay":0,"ttmEps":-3.154987,"open":14.63,"prevYearClose":9.72,"prevWeekClose":14.77,"prevMonthClose":11.2,"prevQuarterClose":11.07,"fiveDayClose":14.63,"twentyDayClose":8.63,"sixtyDayClose":4.68},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/REPL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"REPL","fiscalQuarterEnding":"2026/06","expectedEps":-0.72,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"pre","actualEps":-0.72},{"market":"US","date":"2026-06-29","symbol":"REPL","fiscalQuarterEnding":"2026/03","expectedEps":-0.73,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1782705600000,"reportTimeType":"pre","actualEps":-0.76},{"market":"US","date":"2026-02-03","symbol":"REPL","fiscalQuarterEnding":"2025/12","expectedEps":-0.85,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1770094800000,"reportTimeType":"pre","actualEps":-0.77},{"market":"US","date":"2025-11-06","symbol":"REPL","fiscalQuarterEnding":"2025/09","expectedEps":-0.87,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.9},{"market":"US","date":"2025-08-07","symbol":"REPL","fiscalQuarterEnding":"2025/06","expectedEps":-0.83,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.95}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"REPL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"REPL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.5,"hold":0,"sell":0.125,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":8,"updateTime":1785816000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/REPL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"REPL","date":"2026-08-21","current":-4.730606,"percent":0.472454,"low":-17.365275,"twenty":-7.642831,"median":-3.936989,"eighty":-2.258937,"high":-0.445838,"avg":-5.345182,"sd":3.820445,"marketCap":1323785857},"quantilePoints":[{"date":"2021-08-27","current":-16.22547,"twenty":-21.895726,"median":-16.15228,"eighty":-13.431331,"marketCap":1471455393},{"date":"2021-09-03","current":-16.988778,"twenty":-21.874892,"median":-16.19167,"eighty":-13.433519,"marketCap":1540678343},{"date":"2021-09-10","current":-16.514289,"twenty":-21.847873,"median":-16.210444,"eighty":-13.441423,"marketCap":1497647861},{"date":"2021-09-17","current":-16.803109,"twenty":-21.82081,"median":-16.215155,"eighty":-13.475095,"marketCap":1523840328},{"date":"2021-09-24","current":-16.638069,"twenty":-21.723491,"median":-16.238363,"eighty":-13.488815,"marketCap":1508873204},{"date":"2021-10-01","current":-15.240389,"twenty":-21.67427,"median":-16.219027,"eighty":-13.513752,"marketCap":1382120371},{"date":"2021-10-08","current":-15.972753,"twenty":-21.626019,"median":-16.19167,"eighty":-13.533427,"marketCap":1448536985},{"date":"2021-10-15","current":-15.549838,"twenty":-21.540653,"median":-16.15388,"eighty":-13.565594,"marketCap":1410183729},{"date":"2021-10-22","current":-14.961884,"twenty":-21.492962,"median":-16.14312,"eighty":-13.567208,"marketCap":1356863349},{"date":"2021-10-29","current":-15.219759,"twenty":-21.476079,"median":-16.139261,"eighty":-13.574656,"marketCap":1380249481},{"date":"2021-11-05","current":-15.694027,"twenty":-21.451576,"median":-16.135948,"eighty":-13.594071,"marketCap":1568586638},{"date":"2021-11-12","current":-15.689335,"twenty":-21.392191,"median":-16.126343,"eighty":-13.624185,"marketCap":1568117703},{"date":"2021-11-19","current":-16.06937,"twenty":-21.266207,"median":-16.114408,"eighty":-13.633329,"marketCap":1606101416},{"date":"2021-11-26","current":-13.606182,"twenty":-21.237353,"median":-16.104262,"eighty":-13.632281,"marketCap":1359910688},{"date":"2021-12-03","current":-12.977483,"twenty":-21.223934,"median":-16.091557,"eighty":-13.587048,"marketCap":1297073435},{"date":"2021-12-10","current":-12.907106,"twenty":-21.205376,"median":-16.076662,"eighty":-13.56612,"marketCap":1290039414},{"date":"2021-12-17","current":-12.311249,"twenty":-21.124959,"median":-16.069894,"eighty":-13.48331,"marketCap":1230484705},{"date":"2021-12-23","current":-13.517038,"twenty":-21.122485,"median":-16.044742,"eighty":-13.433519,"marketCap":1351000928},{"date":"2021-12-31","current":-12.714743,"twenty":-21.069904,"median":-16.015764,"eighty":-13.41643,"marketCap":1270813091},{"date":"2022-01-07","current":-12.189262,"twenty":-21.03217,"median":-16.010593,"eighty":-13.380684,"marketCap":1218292402},{"date":"2022-01-14","current":-11.199295,"twenty":-21.025984,"median":-15.986212,"eighty":-13.311118,"marketCap":1119347176},{"date":"2022-01-21","current":-9.74015,"twenty":-21.006293,"median":-15.955897,"eighty":-13.293375,"marketCap":973508478},{"date":"2022-01-28","current":-8.731415,"twenty":-20.94976,"median":-15.905705,"eighty":-13.286213,"marketCap":872687513},{"date":"2022-02-04","current":-7.99328,"twenty":-20.910732,"median":-15.895098,"eighty":-13.233597,"marketCap":861987330},{"date":"2022-02-11","current":-7.673724,"twenty":-20.897089,"median":-15.869823,"eighty":-13.195305,"marketCap":827526719},{"date":"2022-02-18","current":-7.047744,"twenty":-20.882104,"median":-15.845206,"eighty":-13.132121,"marketCap":760021687},{"date":"2022-02-25","current":-7.183446,"twenty":-20.847524,"median":-15.829866,"eighty":-13.09789,"marketCap":774655645},{"date":"2022-03-04","current":-6.728188,"twenty":-20.805093,"median":-15.823685,"eighty":-13.048554,"marketCap":725561076},{"date":"2022-03-11","current":-7.157181,"twenty":-20.790794,"median":-15.81014,"eighty":-12.996831,"marketCap":771823266},{"date":"2022-03-18","current":-7.179069,"twenty":-20.744594,"median":-15.804542,"eighty":-12.973236,"marketCap":774183582},{"date":"2022-03-25","current":-6.999592,"twenty":-20.701197,"median":-15.776661,"eighty":-12.940996,"marketCap":754828992},{"date":"2022-04-01","current":-7.99328,"twenty":-20.631971,"median":-15.738739,"eighty":-12.832728,"marketCap":861987330},{"date":"2022-04-08","current":-8.5142,"twenty":-20.531056,"median":-15.706391,"eighty":-12.758307,"marketCap":918162846},{"date":"2022-04-14","current":-7.774406,"twenty":-20.522449,"median":-15.696716,"eighty":-12.748252,"marketCap":838384172},{"date":"2022-04-22","current":-8.01079,"twenty":-20.493993,"median":-15.689335,"eighty":-12.730018,"marketCap":863875582},{"date":"2022-04-29","current":-7.341035,"twenty":-20.416327,"median":-15.662226,"eighty":-12.654887,"marketCap":791649919},{"date":"2022-05-06","current":-6.452407,"twenty":-20.38299,"median":-15.655671,"eighty":-12.538835,"marketCap":695821097},{"date":"2022-05-13","current":-6.491804,"twenty":-20.292997,"median":-15.6402,"eighty":-12.449348,"marketCap":700069666},{"date":"2022-05-20","current":-6.148507,"twenty":-20.245319,"median":-15.637726,"eighty":-12.395603,"marketCap":725745226},{"date":"2022-05-27","current":-6.235809,"twenty":-20.234774,"median":-15.631638,"eighty":-12.379449,"marketCap":736049925},{"date":"2022-06-03","current":-6.809503,"twenty":-20.212392,"median":-15.622317,"eighty":-12.311955,"marketCap":803766518},{"date":"2022-06-10","current":-6.468612,"twenty":-20.203255,"median":-15.607654,"eighty":-12.134279,"marketCap":763529122},{"date":"2022-06-17","current":-6.318953,"twenty":-20.189959,"median":-15.595469,"eighty":-11.992537,"marketCap":745863924},{"date":"2022-06-24","current":-7.699145,"twenty":-20.143355,"median":-15.58377,"eighty":-11.944204,"marketCap":908776307},{"date":"2022-07-01","current":-7.640944,"twenty":-20.124611,"median":-15.580646,"eighty":-11.881776,"marketCap":901906508},{"date":"2022-07-08","current":-8.79249,"twenty":-20.103951,"median":-15.560153,"eighty":-11.848266,"marketCap":1037830394},{"date":"2022-07-15","current":-8.534744,"twenty":-20.061997,"median":-15.550705,"eighty":-11.726024,"marketCap":1007406997},{"date":"2022-07-22","current":-7.782289,"twenty":-20.016455,"median":-15.527958,"eighty":-11.633525,"marketCap":918590306},{"date":"2022-07-29","current":-8.053709,"twenty":-19.98877,"median":-15.522807,"eighty":-11.543915,"marketCap":950627642},{"date":"2022-08-05","current":-7.601167,"twenty":-19.981078,"median":-15.512904,"eighty":-11.450611,"marketCap":1010788047},{"date":"2022-08-12","current":-7.515886,"twenty":-19.970963,"median":-15.503521,"eighty":-11.34073,"marketCap":999447498},{"date":"2022-08-19","current":-7.145097,"twenty":-19.933441,"median":-15.494489,"eighty":-11.242484,"marketCap":950140764},{"date":"2022-08-26","current":-7.108019,"twenty":-19.888487,"median":-15.449739,"eighty":-11.188671,"marketCap":945210090},{"date":"2022-09-02","current":-6.993074,"twenty":-19.816752,"median":-15.442937,"eighty":-10.953866,"marketCap":929925003},{"date":"2022-09-09","current":-6.80768,"twenty":-19.756813,"median":-15.436976,"eighty":-10.890541,"marketCap":905271636},{"date":"2022-09-16","current":-6.110597,"twenty":-19.689634,"median":-15.431329,"eighty":-10.778331,"marketCap":812574976},{"date":"2022-09-23","current":-5.888124,"twenty":-19.622483,"median":-15.403136,"eighty":-10.685646,"marketCap":782990935},{"date":"2022-09-30","current":-6.40352,"twenty":-19.571492,"median":-15.3916,"eighty":-10.533097,"marketCap":851527296},{"date":"2022-10-07","current":-6.407228,"twenty":-19.534008,"median":-15.373891,"eighty":-10.386415,"marketCap":852020363},{"date":"2022-10-14","current":-6.918916,"twenty":-19.530951,"median":-15.351275,"eighty":-10.014098,"marketCap":920063656},{"date":"2022-10-21","current":-7.104311,"twenty":-19.514142,"median":-15.301721,"eighty":-9.807604,"marketCap":944717023},{"date":"2022-10-28","current":-6.700151,"twenty":-19.463693,"median":-15.295377,"eighty":-9.668193,"marketCap":890972683},{"date":"2022-11-04","current":-6.285013,"twenty":-19.412753,"median":-15.286558,"eighty":-9.346952,"marketCap":922168605},{"date":"2022-11-11","current":-7.118947,"twenty":-19.397565,"median":-15.277234,"eighty":-9.233032,"marketCap":1044527547},{"date":"2022-11-18","current":-6.451122,"twenty":-19.391261,"median":-15.249135,"eighty":-9.01396,"marketCap":946540915},{"date":"2022-11-25","current":-6.77656,"twenty":-19.371343,"median":-15.242339,"eighty":-8.798362,"marketCap":994290745},{"date":"2022-12-02","current":-6.888429,"twenty":-19.304205,"median":-15.235232,"eighty":-8.708895,"marketCap":1010704750},{"date":"2022-12-09","current":-9.390679,"twenty":-19.279831,"median":-15.219759,"eighty":-8.63141,"marketCap":1377847325},{"date":"2022-12-16","current":-10.475589,"twenty":-19.272597,"median":-15.211631,"eighty":-8.66615,"marketCap":1537030766},{"date":"2022-12-23","current":-10.317569,"twenty":-19.263359,"median":-15.167534,"eighty":-8.683543,"marketCap":1513845240},{"date":"2022-12-30","current":-10.483297,"twenty":-19.232063,"median":-15.140954,"eighty":-8.703265,"marketCap":1538161768},{"date":"2023-01-06","current":-9.951424,"twenty":-19.172861,"median":-15.102526,"eighty":-8.725785,"marketCap":1460122678},{"date":"2023-01-13","current":-10.814754,"twenty":-19.157758,"median":-15.094278,"eighty":-8.739746,"marketCap":1586794823},{"date":"2023-01-20","current":-10.571943,"twenty":-19.139105,"median":-15.069399,"eighty":-8.744456,"marketCap":1551168282},{"date":"2023-01-27","current":-9.978403,"twenty":-19.098984,"median":-15.054481,"eighty":-8.773977,"marketCap":1464081182},{"date":"2023-02-03","current":-10.9034,"twenty":-19.078394,"median":-15.010475,"eighty":-8.810107,"marketCap":1599801338},{"date":"2023-02-10","current":-9.011098,"twenty":-19.073536,"median":-14.978305,"eighty":-8.917906,"marketCap":1412408501},{"date":"2023-02-17","current":-8.971338,"twenty":-19.066387,"median":-14.977232,"eighty":-8.826962,"marketCap":1406176454},{"date":"2023-02-24","current":-7.156829,"twenty":-19.047944,"median":-14.961884,"eighty":-8.755293,"marketCap":1121768485},{"date":"2023-03-03","current":-7.96649,"twenty":-18.994109,"median":-14.946412,"eighty":-8.688473,"marketCap":1248675626},{"date":"2023-03-10","current":-6.741154,"twenty":-18.947558,"median":-14.924413,"eighty":-8.617499,"marketCap":1056615265},{"date":"2023-03-17","current":-7.084537,"twenty":-18.937613,"median":-14.892132,"eighty":-8.574334,"marketCap":1110437490},{"date":"2023-03-24","current":-7.1496,"twenty":-18.918827,"median":-14.820632,"eighty":-8.464903,"marketCap":1120635385},{"date":"2023-03-31","current":-6.383313,"twenty":-18.90696,"median":-14.796136,"eighty":-8.404346,"marketCap":1000526840},{"date":"2023-04-06","current":-5.967638,"twenty":-18.893903,"median":-14.769731,"eighty":-8.353404,"marketCap":935373620},{"date":"2023-04-14","current":-5.880889,"twenty":-18.876593,"median":-14.754647,"eighty":-8.240934,"marketCap":921776426},{"date":"2023-04-21","current":-6.014628,"twenty":-18.872042,"median":-14.72342,"eighty":-8.237923,"marketCap":942738767},{"date":"2023-04-28","current":-6.058002,"twenty":-18.865271,"median":-14.673543,"eighty":-8.162132,"marketCap":949537364},{"date":"2023-05-05","current":-6.307407,"twenty":-18.84001,"median":-14.642657,"eighty":-8.111975,"marketCap":988629296},{"date":"2023-05-12","current":-6.773685,"twenty":-18.786092,"median":-14.624593,"eighty":-8.085208,"marketCap":1061714212},{"date":"2023-05-18","current":-6.338918,"twenty":-18.760756,"median":-14.598129,"eighty":-8.043545,"marketCap":1104771993},{"date":"2023-05-26","current":-6.368208,"twenty":-18.750284,"median":-14.595028,"eighty":-8.000284,"marketCap":1109876825},{"date":"2023-06-02","current":-6.12621,"twenty":-18.73441,"median":-14.58914,"eighty":-7.976597,"marketCap":1067700350},{"date":"2023-06-09","current":-7.47875,"twenty":-18.702219,"median":-14.527689,"eighty":-7.936373,"marketCap":1303426402},{"date":"2023-06-16","current":-7.962747,"twenty":-18.69597,"median":-14.518235,"eighty":-7.928773,"marketCap":1387779351},{"date":"2023-06-23","current":-7.796994,"twenty":-18.685243,"median":-14.453528,"eighty":-7.888232,"marketCap":1358891355},{"date":"2023-06-30","current":-7.661077,"twenty":-18.667244,"median":-14.399755,"eighty":-7.855942,"marketCap":1335203198},{"date":"2023-07-07","current":-7.004698,"twenty":-18.652142,"median":-14.394793,"eighty":-7.843896,"marketCap":1220806732},{"date":"2023-07-14","current":-6.78922,"twenty":-18.6103,"median":-14.376721,"eighty":-7.822971,"marketCap":1183252336},{"date":"2023-07-21","current":-6.80248,"twenty":-18.564048,"median":-14.344533,"eighty":-7.779136,"marketCap":1185563376},{"date":"2023-07-28","current":-6.594113,"twenty":-18.408435,"median":-14.24963,"eighty":-7.705572,"marketCap":1149248430},{"date":"2023-08-04","current":-6.255847,"twenty":-18.227267,"median":-14.198296,"eighty":-7.665176,"marketCap":1135974257},{"date":"2023-08-11","current":-6.335446,"twenty":-18.127797,"median":-14.118082,"eighty":-7.647887,"marketCap":1150428357},{"date":"2023-08-18","current":-6.198991,"twenty":-17.947873,"median":-14.068648,"eighty":-7.573533,"marketCap":1125649900},{"date":"2023-08-25","current":-6.6311,"twenty":-17.81854,"median":-14.004724,"eighty":-7.50913,"marketCap":1204115013},{"date":"2023-09-01","current":-6.634349,"twenty":-17.717437,"median":-13.953723,"eighty":-7.465927,"marketCap":1204704976},{"date":"2023-09-08","current":-6.367936,"twenty":-17.631427,"median":-13.917117,"eighty":-7.434714,"marketCap":1156327989},{"date":"2023-09-15","current":-6.013801,"twenty":-17.579267,"median":-13.810922,"eighty":-7.397943,"marketCap":1092021994},{"date":"2023-09-28","current":-5.393252,"twenty":-17.366758,"median":-13.743606,"eighty":-7.371559,"marketCap":979339011},{"date":"2023-10-06","current":-5.234053,"twenty":-17.358495,"median":-13.711323,"eighty":-7.341615,"marketCap":950430811},{"date":"2023-10-13","current":-4.792197,"twenty":-17.358973,"median":-13.704061,"eighty":-7.315646,"marketCap":870195808},{"date":"2023-10-19","current":-4.649243,"twenty":-17.359211,"median":-13.6531,"eighty":-7.277231,"marketCap":844237425},{"date":"2023-10-23","current":-4.821437,"twenty":-17.35945,"median":-13.643461,"eighty":-7.266629,"marketCap":875505477},{"date":"2023-10-31","current":-4.6265,"twenty":-17.364158,"median":-13.606182,"eighty":-7.244347,"marketCap":840107682},{"date":"2023-11-10","current":-3.415142,"twenty":-17.32282,"median":-13.521228,"eighty":-7.181695,"marketCap":678001257},{"date":"2023-11-17","current":-3.070058,"twenty":-17.327339,"median":-13.433519,"eighty":-7.15697,"marketCap":609492419},{"date":"2023-11-24","current":-3.090882,"twenty":-17.327339,"median":-13.422358,"eighty":-7.134315,"marketCap":613626573},{"date":"2023-12-01","current":-3.325896,"twenty":-17.327339,"median":-13.311118,"eighty":-7.115651,"marketCap":660283454},{"date":"2023-12-08","current":-2.260895,"twenty":-17.32282,"median":-13.291275,"eighty":-7.101345,"marketCap":448851006},{"date":"2023-12-15","current":-2.308493,"twenty":-17.32282,"median":-13.255017,"eighty":-7.080326,"marketCap":458300501},{"date":"2023-12-22","current":-2.290644,"twenty":-17.32282,"median":-13.177521,"eighty":-7.039837,"marketCap":454756941},{"date":"2023-12-29","current":-2.555407,"twenty":-17.327339,"median":-13.141695,"eighty":-7.025096,"marketCap":507319756},{"date":"2024-01-05","current":-2.620854,"twenty":-17.331857,"median":-13.153424,"eighty":-7.015385,"marketCap":520312811},{"date":"2024-01-12","current":-2.620854,"twenty":-17.331857,"median":-13.153424,"eighty":-6.998149,"marketCap":520312811},{"date":"2024-01-19","current":-2.27577,"twenty":-17.336375,"median":-13.165154,"eighty":-6.976101,"marketCap":451803973},{"date":"2024-01-26","current":-2.347166,"twenty":-17.331857,"median":-13.153424,"eighty":-6.953227,"marketCap":465978216},{"date":"2024-02-02","current":-2.338242,"twenty":-17.331857,"median":-13.131353,"eighty":-6.92926,"marketCap":464206435},{"date":"2024-02-09","current":-2.257183,"twenty":-17.331857,"median":-13.069432,"eighty":-6.885152,"marketCap":473913707},{"date":"2024-02-16","current":-2.23964,"twenty":-17.304882,"median":-13.00772,"eighty":-6.857169,"marketCap":470230440},{"date":"2024-02-23","current":-2.324431,"twenty":-17.304882,"median":-12.978804,"eighty":-6.834348,"marketCap":488032898},{"date":"2024-03-01","current":-2.508631,"twenty":-17.29598,"median":-12.943915,"eighty":-6.80768,"marketCap":526707203},{"date":"2024-03-08","current":-2.58465,"twenty":-17.29598,"median":-12.874263,"eighty":-6.789321,"marketCap":542668028},{"date":"2024-03-15","current":-2.58465,"twenty":-17.29598,"median":-12.874263,"eighty":-6.773685,"marketCap":542668028},{"date":"2024-03-22","current":-2.397526,"twenty":-17.29598,"median":-12.760313,"eighty":-6.739451,"marketCap":503379845},{"date":"2024-03-28","current":-2.412145,"twenty":-17.29598,"median":-12.747585,"eighty":-6.71682,"marketCap":506449234},{"date":"2024-04-05","current":-2.146078,"twenty":-17.304882,"median":-12.701477,"eighty":-6.680523,"marketCap":450586349},{"date":"2024-04-12","current":-2.102221,"twenty":-17.261345,"median":-12.582004,"eighty":-6.649243,"marketCap":441378181},{"date":"2024-04-19","current":-2.037897,"twenty":-17.261345,"median":-12.418128,"eighty":-6.619319,"marketCap":427872868},{"date":"2024-04-26","current":-1.798145,"twenty":-17.253415,"median":-12.311955,"eighty":-6.599292,"marketCap":377534883},{"date":"2024-05-03","current":-1.918021,"twenty":-17.253415,"median":-12.073728,"eighty":-6.568396,"marketCap":402703876},{"date":"2024-05-10","current":-1.967726,"twenty":-17.253415,"median":-11.686636,"eighty":-6.523016,"marketCap":413139799},{"date":"2024-05-17","current":-1.912516,"twenty":-17.253415,"median":-11.471468,"eighty":-6.489603,"marketCap":412709505},{"date":"2024-05-24","current":-1.610839,"twenty":-17.253415,"median":-11.245895,"eighty":-6.455856,"marketCap":347609494},{"date":"2024-05-31","current":-1.451463,"twenty":-17.253415,"median":-11.199295,"eighty":-6.429551,"marketCap":313217035},{"date":"2024-06-07","current":-2.02351,"twenty":-17.253415,"median":-11.019024,"eighty":-6.403667,"marketCap":436661396},{"date":"2024-06-14","current":-2.692322,"twenty":-17.261345,"median":-10.931572,"eighty":-6.396942,"marketCap":580986893},{"date":"2024-06-21","current":-2.239807,"twenty":-17.269275,"median":-10.852478,"eighty":-6.368208,"marketCap":483336876},{"date":"2024-06-28","current":-2.424797,"twenty":-17.29598,"median":-10.804126,"eighty":-6.362258,"marketCap":523256694},{"date":"2024-07-05","current":-2.302419,"twenty":-17.29598,"median":-10.763984,"eighty":-6.338722,"marketCap":496848199},{"date":"2024-07-12","current":-2.823238,"twenty":-17.29598,"median":-10.704911,"eighty":-6.326195,"marketCap":609237841},{"date":"2024-07-15","current":-2.948462,"twenty":-17.29598,"median":-10.672408,"eighty":-6.321564,"marketCap":636260487},{"date":"2024-08-02","current":-3.2357,"twenty":-17.360806,"median":-10.556526,"eighty":-6.30697,"marketCap":698244667},{"date":"2024-08-09","current":-2.934568,"twenty":-17.360806,"median":-10.481741,"eighty":-6.280817,"marketCap":645637192},{"date":"2024-08-16","current":-3.198524,"twenty":-17.360806,"median":-10.336007,"eighty":-6.231015,"marketCap":703710378},{"date":"2024-08-23","current":-3.148838,"twenty":-17.360806,"median":-10.221215,"eighty":-6.160784,"marketCap":692778955},{"date":"2024-08-30","current":-3.434531,"twenty":-17.360806,"median":-10.111004,"eighty":-6.142122,"marketCap":755634639},{"date":"2024-09-06","current":-3.328949,"twenty":-17.360806,"median":-10.055486,"eighty":-6.110199,"marketCap":732405365},{"date":"2024-09-13","current":-3.223367,"twenty":-17.360806,"median":-9.951424,"eighty":-6.072015,"marketCap":709176090},{"date":"2024-09-20","current":-3.487322,"twenty":-17.360806,"median":-9.824237,"eighty":-6.050554,"marketCap":767249277},{"date":"2024-09-27","current":-3.456269,"twenty":-17.341038,"median":-9.672861,"eighty":-6.031978,"marketCap":760417137},{"date":"2024-10-04","current":-3.630169,"twenty":-17.341038,"median":-9.390679,"eighty":-5.972448,"marketCap":798677119},{"date":"2024-10-11","current":-3.453163,"twenty":-17.341038,"median":-9.226291,"eighty":-5.909884,"marketCap":759733923},{"date":"2024-10-18","current":-3.512165,"twenty":-17.341038,"median":-9.011098,"eighty":-5.876626,"marketCap":772714988},{"date":"2024-10-25","current":-3.714014,"twenty":-17.341038,"median":-8.90989,"eighty":-5.795064,"marketCap":817123896},{"date":"2024-10-31","current":-3.760594,"twenty":-17.341038,"median":-8.768922,"eighty":-5.525809,"marketCap":827372105},{"date":"2024-11-08","current":-3.791648,"twenty":-17.205109,"median":-8.678585,"eighty":-5.069007,"marketCap":834204245},{"date":"2024-11-15","current":-3.661401,"twenty":-17.192664,"median":-8.604536,"eighty":-4.715521,"marketCap":779958861},{"date":"2024-11-22","current":-3.548989,"twenty":-17.192664,"median":-8.493293,"eighty":-3.820091,"marketCap":756012756},{"date":"2024-11-29","current":-4.522151,"twenty":-17.192664,"median":-8.424021,"eighty":-3.820091,"marketCap":963317611},{"date":"2024-12-06","current":-4.615452,"twenty":-17.192664,"median":-8.333153,"eighty":-3.820091,"marketCap":983192794},{"date":"2024-12-13","current":-4.321902,"twenty":-17.192664,"median":-8.240025,"eighty":-3.820091,"marketCap":920660225},{"date":"2024-12-20","current":-4.24763,"twenty":-17.192664,"median":-8.201035,"eighty":-3.820091,"marketCap":904838732},{"date":"2024-12-27","current":-4.523497,"twenty":-17.192664,"median":-8.13773,"eighty":-3.820091,"marketCap":963604278},{"date":"2025-01-03","current":-4.537396,"twenty":-17.192664,"median":-8.078641,"eighty":-3.820091,"marketCap":966565111},{"date":"2025-01-10","current":-4.1653,"twenty":-17.196713,"median":-8.023922,"eighty":-3.817856,"marketCap":887300616},{"date":"2025-01-17","current":-3.742629,"twenty":-17.078146,"median":-7.988903,"eighty":-3.790414,"marketCap":797262305},{"date":"2025-01-24","current":-4.967292,"twenty":-16.990879,"median":-7.962747,"eighty":-3.774419,"marketCap":1058142538},{"date":"2025-01-31","current":-4.920329,"twenty":-16.953236,"median":-7.899761,"eighty":-3.774419,"marketCap":1048138282},{"date":"2025-02-07","current":-5.079282,"twenty":-16.830086,"median":-7.844848,"eighty":-3.774419,"marketCap":1081998843},{"date":"2025-02-14","current":-4.821817,"twenty":-16.78929,"median":-7.805048,"eighty":-3.774419,"marketCap":1100541220},{"date":"2025-02-21","current":-4.828566,"twenty":-16.78929,"median":-7.774406,"eighty":-3.774419,"marketCap":1102081516},{"date":"2025-02-28","current":-4.263377,"twenty":-16.78929,"median":-7.699145,"eighty":-3.774419,"marketCap":973081757},{"date":"2025-03-07","current":-3.961381,"twenty":-16.791042,"median":-7.658931,"eighty":-3.769362,"marketCap":904153528},{"date":"2025-03-14","current":-4.001872,"twenty":-16.791042,"median":-7.643303,"eighty":-3.761336,"marketCap":913395302},{"date":"2025-03-21","current":-3.914141,"twenty":-16.791042,"median":-7.573195,"eighty":-3.761336,"marketCap":893371459},{"date":"2025-03-28","current":-3.526102,"twenty":-16.791042,"median":-7.503948,"eighty":-3.734509,"marketCap":804804461},{"date":"2025-04-04","current":-2.662291,"twenty":-16.791042,"median":-7.445715,"eighty":-3.714635,"marketCap":607646622},{"date":"2025-04-11","current":-2.334988,"twenty":-16.78929,"median":-7.411075,"eighty":-3.662101,"marketCap":532942284},{"date":"2025-04-17","current":-2.57456,"twenty":-16.78929,"median":-7.377317,"eighty":-3.643832,"marketCap":587622779},{"date":"2025-04-25","current":-3.057079,"twenty":-16.791042,"median":-7.330201,"eighty":-3.582346,"marketCap":697753915},{"date":"2025-05-02","current":-3.252786,"twenty":-16.791042,"median":-7.279839,"eighty":-3.541256,"marketCap":742422488},{"date":"2025-05-09","current":-2.6218,"twenty":-16.791042,"median":-7.234737,"eighty":-3.513106,"marketCap":598404848},{"date":"2025-05-16","current":-2.43959,"twenty":-16.777387,"median":-7.178793,"eighty":-3.476302,"marketCap":556816866},{"date":"2025-05-23","current":-2.730643,"twenty":-16.657668,"median":-7.147348,"eighty":-3.456269,"marketCap":675279930},{"date":"2025-05-30","current":-2.920791,"twenty":-16.652724,"median":-7.131505,"eighty":-3.437637,"marketCap":722302847},{"date":"2025-06-06","current":-3.039244,"twenty":-16.636006,"median":-7.108524,"eighty":-3.417157,"marketCap":751595812},{"date":"2025-06-13","current":-3.081325,"twenty":-16.625774,"median":-7.092688,"eighty":-3.377634,"marketCap":762002523},{"date":"2025-06-20","current":-2.958197,"twenty":-16.627754,"median":-7.067232,"eighty":-3.325896,"marketCap":731553257},{"date":"2025-06-27","current":-2.948846,"twenty":-16.544737,"median":-7.037548,"eighty":-3.285474,"marketCap":729240655},{"date":"2025-07-03","current":-2.930143,"twenty":-16.498817,"median":-7.021479,"eighty":-3.248209,"marketCap":724615450},{"date":"2025-07-11","current":-3.357195,"twenty":-16.442084,"median":-6.999592,"eighty":-3.235625,"marketCap":830224297},{"date":"2025-07-18","current":-3.896466,"twenty":-16.364758,"median":-6.976101,"eighty":-3.235625,"marketCap":963584375},{"date":"2025-07-25","current":-0.966324,"twenty":-16.32862,"median":-6.95293,"eighty":-3.220261,"marketCap":238968925},{"date":"2025-08-01","current":-2.211852,"twenty":-16.32862,"median":-6.926755,"eighty":-3.197708,"marketCap":546984433},{"date":"2025-08-08","current":-1.521613,"twenty":-16.25891,"median":-6.884333,"eighty":-3.189052,"marketCap":426383313},{"date":"2025-08-15","current":-1.490264,"twenty":-16.251257,"median":-6.855232,"eighty":-3.157696,"marketCap":417598776},{"date":"2025-08-22","current":-1.559902,"twenty":-16.251257,"median":-6.81724,"eighty":-3.102781,"marketCap":437112737},{"date":"2025-08-29","current":-1.498621,"twenty":-16.22547,"median":-6.802605,"eighty":-3.090882,"marketCap":419940451},{"date":"2025-09-05","current":-1.618399,"twenty":-16.215929,"median":-6.784969,"eighty":-3.068883,"marketCap":453504465},{"date":"2025-09-12","current":-1.67411,"twenty":-16.132635,"median":-6.773685,"eighty":-3.048595,"marketCap":469115634},{"date":"2025-09-19","current":-0.963797,"twenty":-16.075902,"median":-6.738316,"eighty":-3.021518,"marketCap":270073227},{"date":"2025-09-26","current":-1.128144,"twenty":-16.075902,"median":-6.70973,"eighty":-2.979471,"marketCap":316126176},{"date":"2025-10-03","current":-1.295276,"twenty":-16.070745,"median":-6.676586,"eighty":-2.957539,"marketCap":362959683},{"date":"2025-10-10","current":-1.289705,"twenty":-15.972753,"median":-6.634349,"eighty":-2.934568,"marketCap":361398566},{"date":"2025-10-17","current":-1.300847,"twenty":-15.720035,"median":-6.618272,"eighty":-2.911439,"marketCap":364520800},{"date":"2025-10-24","current":-2.345425,"twenty":-15.642673,"median":-6.590111,"eighty":-2.877151,"marketCap":657230223},{"date":"2025-10-31","current":-2.855179,"twenty":-15.609575,"median":-6.559251,"eighty":-2.844036,"marketCap":800072421},{"date":"2025-11-07","current":-2.138427,"twenty":-15.549838,"median":-6.518465,"eighty":-2.766893,"marketCap":663474691},{"date":"2025-11-14","current":-2.2704,"twenty":-15.403136,"median":-6.4784,"eighty":-2.692322,"marketCap":704421139},{"date":"2025-11-21","current":-2.277985,"twenty":-15.271334,"median":-6.451122,"eighty":-2.648794,"marketCap":706774439},{"date":"2025-11-28","current":-2.561153,"twenty":-15.219759,"median":-6.429475,"eighty":-2.625584,"marketCap":794630973},{"date":"2025-12-05","current":-2.662284,"twenty":-14.946412,"median":-6.40352,"eighty":-2.620854,"marketCap":826008307},{"date":"2025-12-12","current":-2.495417,"twenty":-13.958066,"median":-6.383313,"eighty":-2.604134,"marketCap":774235706},{"date":"2025-12-19","current":-2.449908,"twenty":-13.596799,"median":-6.36048,"eighty":-2.596346,"marketCap":760115906},{"date":"2025-12-26","current":-2.55104,"twenty":-13.291832,"median":-6.338592,"eighty":-2.58465,"marketCap":791493240},{"date":"2026-01-02","current":-2.457493,"twenty":-13.118236,"median":-6.327267,"eighty":-2.573794,"marketCap":762469206},{"date":"2026-01-09","current":-2.080779,"twenty":-12.963407,"median":-6.307407,"eighty":-2.55104,"marketCap":645588638},{"date":"2026-01-16","current":-1.845648,"twenty":-12.714743,"median":-6.285013,"eighty":-2.534069,"marketCap":572636338},{"date":"2026-01-23","current":-1.997345,"twenty":-12.311249,"median":-6.235116,"eighty":-2.528285,"marketCap":619702338},{"date":"2026-01-30","current":-1.868403,"twenty":-11.211732,"median":-6.162507,"eighty":-2.517403,"marketCap":579696238},{"date":"2026-02-06","current":-1.817446,"twenty":-11.019024,"median":-6.148507,"eighty":-2.510177,"marketCap":572228249},{"date":"2026-02-13","current":-2.092816,"twenty":-10.814754,"median":-6.110597,"eighty":-2.497946,"marketCap":658929499},{"date":"2026-02-20","current":-2.242303,"twenty":-10.706838,"median":-6.07878,"eighty":-2.482776,"marketCap":705995892},{"date":"2026-02-27","current":-2.016762,"twenty":-10.556526,"median":-6.058002,"eighty":-2.458949,"marketCap":634983440},{"date":"2026-03-06","current":-1.846294,"twenty":-10.40236,"median":-6.036439,"eighty":-2.442323,"marketCap":581311237},{"date":"2026-03-13","current":-1.987913,"twenty":-10.248194,"median":-5.978062,"eighty":-2.420917,"marketCap":625900452},{"date":"2026-03-20","current":-1.806955,"twenty":-10.117153,"median":-5.91342,"eighty":-2.412145,"marketCap":568925344},{"date":"2026-03-27","current":-1.977423,"twenty":-9.978403,"median":-5.880889,"eighty":-2.397739,"marketCap":622597547},{"date":"2026-04-02","current":-1.995781,"twenty":-9.924445,"median":-5.830805,"eighty":-2.391192,"marketCap":628377630},{"date":"2026-04-10","current":-1.549943,"twenty":-9.665081,"median":-5.656786,"eighty":-2.37406,"marketCap":488004178},{"date":"2026-04-17","current":-0.574344,"twenty":-9.087991,"median":-5.234053,"eighty":-2.347166,"marketCap":180834035},{"date":"2026-04-24","current":-0.747434,"twenty":-8.83037,"median":-5.064832,"eighty":-2.334988,"marketCap":235331964},{"date":"2026-05-01","current":-0.674002,"twenty":-8.731415,"median":-4.967292,"eighty":-2.311998,"marketCap":212211630},{"date":"2026-05-08","current":-0.875941,"twenty":-8.613496,"median":-4.909491,"eighty":-2.308324,"marketCap":275792547},{"date":"2026-05-15","current":-1.29293,"twenty":-8.5142,"median":-4.792197,"eighty":-2.28557,"marketCap":407083011},{"date":"2026-05-22","current":-1.368985,"twenty":-8.410027,"median":-4.717215,"eighty":-2.272928,"marketCap":431029071},{"date":"2026-05-29","current":-1.227366,"twenty":-8.239582,"median":-4.649393,"eighty":-2.265382,"marketCap":386439856},{"date":"2026-06-05","current":-2.588483,"twenty":-8.15628,"median":-4.618503,"eighty":-2.265906,"marketCap":814991749},{"date":"2026-06-12","current":-2.260661,"twenty":-8.100229,"median":-4.551876,"eighty":-2.260895,"marketCap":711775975},{"date":"2026-06-18","current":-2.622577,"twenty":-8.053709,"median":-4.522151,"eighty":-2.260895,"marketCap":825726190},{"date":"2026-06-26","current":-2.918928,"twenty":-7.99007,"median":-4.429773,"eighty":-2.260848,"marketCap":919033249},{"date":"2026-07-02","current":-3.000142,"twenty":-7.963496,"median":-4.387332,"eighty":-2.260848,"marketCap":941864706},{"date":"2026-07-10","current":-2.970729,"twenty":-7.901087,"median":-4.30245,"eighty":-2.260848,"marketCap":932630738},{"date":"2026-07-17","current":-2.545575,"twenty":-7.845639,"median":-4.253208,"eighty":-2.260848,"marketCap":799157932},{"date":"2026-07-24","current":-2.796924,"twenty":-7.809529,"median":-4.134455,"eighty":-2.260848,"marketCap":878066384},{"date":"2026-07-31","current":-1.446921,"twenty":-7.7639,"median":-4.046085,"eighty":-2.258937,"marketCap":454246424},{"date":"2026-08-07","current":-3.439447,"twenty":-7.691772,"median":-3.943811,"eighty":-2.258937,"marketCap":1079779856},{"date":"2026-08-14","current":-4.535012,"twenty":-7.658502,"median":-3.936989,"eighty":-2.258937,"marketCap":1423721651},{"date":"2026-08-21","current":-4.456996,"twenty":-7.642831,"median":-3.936989,"eighty":-2.258937,"marketCap":1323785857}],"updateTime":1787599310910},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"REPL\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627311794","title":"Replimune downgraded to Sell from Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2627311794","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627311794?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:10","pubTimestamp":1776075029,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Robert Burns double downgraded Replimune (REPL) to Sell from Buy without a price target after the FDA issued another comple...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/replimune-downgraded-to-sell-from-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/replimune-downgraded-to-sell-from-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4139","BK4588","BK4585","REPL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627435162","title":"BUZZ-Replimune slumps after FDA drug rejection prompts downgrades","url":"https://stock-news.laohu8.com/highlight/detail?id=2627435162","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627435162?lang=en_us&edition=fundamental","pubTime":"2026-04-13 17:01","pubTimestamp":1776070913,"startTime":"0","endTime":"0","summary":"BUZZ-Replimune slumps after FDA drug rejection prompts downgrades** Shares of Replimune REPL.O plunge 56% to $2.09 premarket ** J.P. Morgan downgrades biotech firm's stock to \"underweight\" from \"neutral\", withdraws price target of $10** JPM says the U.S. Food and Drug Administration's second complete response letter  highlights concerns over design of REPL's trials for its drug to treat advanced skin cancer ** The CRL creates \"greater uncertainty\" over the prospects of the therapy and whether data from the trials will be satisfactory for the FDA - brokerage** Piper Sandler also downgrades stock to \"neutral\" from \"overweight\" ** The regulator declined to approve REPL's drug for a second time on Friday, citing insufficient data from studies ** The second consecutive rejection sent the stock down more than 19% in the previous session** Five analysts rate stock \"buy\" or higher, two \"hold\" and one \"sell\", median PT at $11.50 - data compiled by LSEG ** REPL has lost more than half its value ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL4N40W0IK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REPL","BK4127","LU0053671581.USD","PIPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627438191","title":"Replimune Shares Decline 58% Premarket After at Least Two Brokerages Downgrade Stock After Advanced Skin Cancer Fails to Win FDA Nod","url":"https://stock-news.laohu8.com/highlight/detail?id=2627438191","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627438191?lang=en_us&edition=fundamental","pubTime":"2026-04-13 16:07","pubTimestamp":1776067632,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL4N40W0GK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REPL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627869754","title":"Replimune Group Inc : JP Morgan Cuts to Underweight From Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2627869754","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627869754?lang=en_us&edition=fundamental","pubTime":"2026-04-13 12:19","pubTimestamp":1776053968,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nFWN40U0HG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REPL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627510176","title":"Replimune downgraded to Hold from Buy at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2627510176","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627510176?lang=en_us&edition=fundamental","pubTime":"2026-04-13 07:15","pubTimestamp":1776035705,"startTime":"0","endTime":"0","summary":"Jefferies downgraded Replimune (REPL) to Hold from Buy with a price target of $2, down from $13. The firm sees a “tough road ahead” for the company...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/replimune-downgraded-to-hold-from-buy-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/replimune-downgraded-to-hold-from-buy-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REPL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626414399","title":"BRIEF-Replimune Group Disagrees With FDA About Whether Rp1 BLA Data Set Is Enough To Allow The Medicine To Be Made Available To Advanced Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2626414399","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626414399?lang=en_us&edition=fundamental","pubTime":"2026-04-11 05:11","pubTimestamp":1775855484,"startTime":"0","endTime":"0","summary":"BRIEF-Replimune Group Disagrees With FDA About Whether Rp1 BLA Data Set Is Enough To Allow The Medicine To Be Made Available To Advanced Cancer PatientsApril 10 (Reuters) - Replimune Group Inc REPL.O:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nFWN40T0T1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REPL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626143425","title":"Replimune says FDA’s CRL for RP1 ‘disappointing’","url":"https://stock-news.laohu8.com/highlight/detail?id=2626143425","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626143425?lang=en_us&edition=fundamental","pubTime":"2026-04-11 05:10","pubTimestamp":1775855450,"startTime":"0","endTime":"0","summary":"Replimune (REPL) Group announced that the company received a complete response letter from the U.S. Food and Drug Administration for the Company’s ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/replimune-says-fdas-crl-for-rp1-disappointing-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/replimune-says-fdas-crl-for-rp1-disappointing-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REPL","LABU","LU0029874061.USD","BK4530","LU0128526141.USD","BK4585","BK4121","BK4139","LU0390134368.USD","LU1815336091.USD","IE00BFMHRM44.USD","LU0757428866.USD","BK4588","CRL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626714348","title":"Replimune says FDA ‘appears to have contradicted their positions’ in CRL","url":"https://stock-news.laohu8.com/highlight/detail?id=2626714348","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626714348?lang=en_us&edition=fundamental","pubTime":"2026-04-11 05:10","pubTimestamp":1775855415,"startTime":"0","endTime":"0","summary":"Replimune (REPL) said, “With the CRL, the company learned that a different review team was appointed for the resubmission and replaced the prior te...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/replimune-says-fda-appears-to-have-contradicted-their-positions-in-crl-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/replimune-says-fda-appears-to-have-contradicted-their-positions-in-crl-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRL","REPL","LU0390134368.USD","IE00BFMHRM44.USD","LU0128526141.USD","LU1815336091.USD","LU0757428866.USD","BK4530","LABU","LU0029874061.USD","BK4585","BK4139","BK4588","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626435041","title":"Replimune Group: We Have No Choice but to Eliminate Jobs, Including Substantially Scaling Back Our U.S. Based Manufacturing Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2626435041","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626435041?lang=en_us&edition=fundamental","pubTime":"2026-04-11 05:04","pubTimestamp":1775855050,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nFWN40T0T1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REPL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626143631","title":"Replimune: Based on FDA Feedback, Started Ignyte-3 to Satisfy Regulatory Requirement That Confirmatory Study Be Underway for Accelerated Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2626143631","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626143631?lang=en_us&edition=fundamental","pubTime":"2026-04-11 05:04","pubTimestamp":1775855050,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nFWN40T0T1:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","REPL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626148426","title":"Replimune downgraded to Neutral from Overweight at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2626148426","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626148426?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:20","pubTimestamp":1775852457,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald downgraded Replimune (REPL) to Neutral from Overweight. Published first on TheFly – the ultimate source for real-time, market-mov...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/replimune-downgraded-to-neutral-from-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/replimune-downgraded-to-neutral-from-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","REPL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626110148","title":"Replimune downgraded to Neutral from Overweight at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2626110148","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626110148?lang=en_us&edition=fundamental","pubTime":"2026-04-11 03:40","pubTimestamp":1775850018,"startTime":"0","endTime":"0","summary":"Piper Sandler downgraded Replimune (REPL) to Neutral from Overweight with a $4 price target Published first on TheFly – the ultimate source for rea...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/replimune-downgraded-to-neutral-from-overweight-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/replimune-downgraded-to-neutral-from-overweight-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","REPL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626112379","title":"Sector Update: Health Care Stocks Lower Friday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2626112379","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626112379?lang=en_us&edition=fundamental","pubTime":"2026-04-11 01:54","pubTimestamp":1775843654,"startTime":"0","endTime":"0","summary":"Health care stocks declined Friday afternoon, with the NYSE Health Care Index decreasing 0.7% and the State Street Health Care Select Sector SPDR ETF  falling 1.2%.The iShares Biotechnology ETF  dropped 1.8%.In corporate news, Replimune  shares tumbled 19%. The company's biologics license application for vusolimogene oderparepvec to treat unresectable advanced cutaneous melanoma was rejected by the US Food and Drug Administration, the regulator said in a complete response letter.Abbott Laboratories  has been ordered by a jury in Chicago to pay $53 million in compensatory damages to a group of families related to four cases over its infant formula, the Chicago Tribune reported. The families accused the company of allegedly failing to inform them that its infant formula could develop a dangerous intestinal disease in premature infants, the report said. Abbott shares fell 2.9%.Organon  is closing in on a deal to be acquired by Sun Pharmaceutical Industries for $12 billion, The Economic Ti","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1691799644.USD","BK4592","LU2468319806.SGD","BK4007","LU1989763690.USD","BK4504","LU2065171311.SGD","BK4566","LU1914381329.SGD","LABU","LU2065170008.USD","LU0289739699.SGD","REPL","BK4581","BK4533","LU1721429741.USD","IE0009355771.USD","LU0122379950.USD","LU1061106388.HKD","BK4559","IE00B4R5TH58.HKD","LU2237957902.USD","BK4585","SG9999002232.USD","LU2089984988.USD","LU1989763427.SGD","BK4139","ABT","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU2324357040.USD","LU0266013472.USD","ABT.AU","LU2065169927.USD","SGXZ23171101.USD","LU1023059063.AUD","BK4588","IBB","IE00B2B36J28.USD","LU0058720904.USD","LU0882574055.USD","LU2237957811.SGD","XBI","BK4568","XLV","LU1721429402.USD","LU2112291526.USD","IE00BJT1NW94.SGD","OGN","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626112997","title":"Replimune CRL positive for Iovance in near-term, says Chardan","url":"https://stock-news.laohu8.com/highlight/detail?id=2626112997","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626112997?lang=en_us&edition=fundamental","pubTime":"2026-04-11 01:43","pubTimestamp":1775842993,"startTime":"0","endTime":"0","summary":"Chardan analyst Geulah Livshits keeps a Buy rating on Iovance Biotherapeutics (IOVA) with a $16 price target after Replimune (REPL) received a seco...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/replimune-crl-positive-for-iovance-in-near-term-says-chardan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/replimune-crl-positive-for-iovance-in-near-term-says-chardan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4121","LU0029874061.USD","LU0757428866.USD","BK4588","LU0390134368.USD","LU1815336091.USD","BK4585","REPL","BK4139","CRL","IOVA","BK4530","IE00BFMHRM44.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626114148","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2626114148","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626114148?lang=en_us&edition=fundamental","pubTime":"2026-04-11 01:08","pubTimestamp":1775840913,"startTime":"0","endTime":"0","summary":"One and One Green Technologies  said Friday it signed an agreement with two institutional investors to sell about 1.7 million units in a follow-on offering of its securities at $7.50 per unit, for expected gross proceeds of about $13 million.Shares slid 62%, with intraday trading volume at over 992,000, versus a daily average of roughly 196,000.Angel Studios  said Friday that it priced an underwritten public offering of 14.3 million shares of Class A common stock at $2.10 per share, raising $30 million in expected gross proceeds.Shares sank 26% following an increase in intraday trading volume to over 8.62 million from a daily average of about 762,000.Replimune Group's  biologics license application for vusolimogene oderparepvec was rejected by the US Food and Drug Administration, the regulator said in a complete response letter on Friday.Shares slumped 19% as intraday trading volume soared to more than 2.94 million from a daily average of about 1.75 million.Price: 5.20, Change: -8.71, ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4108","REPL","ANGX","BK4168","YDDL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626745111","title":"BRIEF-FDA Says Data Insufficient To Conclude Effectiveness Of Replimune's vusolimogene oderparepvec","url":"https://stock-news.laohu8.com/highlight/detail?id=2626745111","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626745111?lang=en_us&edition=fundamental","pubTime":"2026-04-11 00:30","pubTimestamp":1775838642,"startTime":"0","endTime":"0","summary":"BRIEF-FDA Says Data Insufficient To Conclude Effectiveness Of Replimune's vusolimogene oderparepvecApril 10 (Reuters) - FDA:FDA, IN COMPLETE RESPONSE LETTER: DATA WAS INSUFFICIENT TO CONCLUDE SUBSTANT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nFWN40T0PN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","REPL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626111521","title":"Replimune Stock Tumbles After FDA Rejects Skin Cancer Therapy for Second Time -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2626111521","media":"Dow Jones","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626111521?lang=en_us&edition=fundamental","pubTime":"2026-04-11 00:17","pubTimestamp":1775837820,"startTime":"0","endTime":"0","summary":"Shares of Replimune Group sank on Friday after an application for an experimental skin cancer drug was rejected by the Food and Drug Administration for the second time.The agency declined to approve Replimune's lead investigational immunotherapy, RP1, in combination with Bristol Myers Squibb's Opdivo for the treatment of advanced melanoma.At last check, Replimune shares were down 19% at $4.76, putting the stock on pace for its lowest close since October, according to Dow Jones Market Data. Trading paused twice due to volatility.The FDA rejected an application for the drug in July, two months after Vinay Prasad was appointed to lead the agency's Center for Biologics Evaluation and Research.Regulators said at the time that a clinical trial evaluating the efficacy of RP1 wasn't adequately controlled and failed to provide \"substantial evidence of effectiveness,\" though the FDA raised no safety concerns.Following that setback, Replimune resubmitted its Biologics License Application, which w","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","LU1670710588.SGD","LU1670711123.USD","IE0002141913.USD","LU1430594728.SGD","LU0225284248.USD","LU1670710661.SGD","REPL","LU0114720955.EUR","LU0868494617.USD","LU1868836591.USD","LU2125154935.USD","BK4139","IE00B2B36J28.USD","LU1093756168.USD","LU1074936037.SGD","LU0061475181.USD","LU0306807586.USD","LU1718418525.SGD","LU1032466523.USD","BK4581","LU0985481810.HKD","LU1868836757.USD","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","LU1323610961.USD","BK4532","LU2133065610.SGD","LU0306806265.USD","BMY","BK4534","LU0882574055.USD","IE00BFXG1179.USD","LU1868836914.USD","LABU","LU1868837300.USD","LU1983299246.USD","IE00BJT1NW94.SGD","LU2242652126.USD","LU0456855351.SGD","LU2242646821.SGD","LU2360032135.SGD","IE00BJJMRZ35.SGD","LU0225771236.USD","LU1261432733.SGD","LU1291159041.SGD","LU0096364046.USD","LU1093756325.SGD","LU0267386448.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626118741","title":"Replimune's Biologics License Application for Advanced Cutaneous Melanoma Drug Rejected by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2626118741","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626118741?lang=en_us&edition=fundamental","pubTime":"2026-04-11 00:00","pubTimestamp":1775836857,"startTime":"0","endTime":"0","summary":"Replimune Group's  biologics license application for vusolimogene oderparepvec was rejected by the US Food and Drug Administration, the regulator said in a complete response letter on Friday.The application was for vusolimogene oderparepvec plus nivolumab to treat adults with unresectable advanced cutaneous melanoma who experienced disease progression with a programmed death receptor-1 blocking antibody-based therapy, the letter said.The regulator and experts unanimously decided that the data presented in the application were \"insufficient\" to show that the treatment is effective for advanced melanoma, the letter added.Shares of Replimune Group were down 19.5% before being halted on Nasdaq at about 11:02 a.m. ET.Price: 4.76, Change: -1.15, Percent Change: -19.46","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0757428866.USD","LABU","IE00B66KJ199.SGD","REPL","IE00B7SZL793.SGD","IE0031619046.USD","AEIS","BK4585","IE00B19Z4B17.USD","LU1815336091.USD","BK4588","BK4157","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626611927","title":"Replimune Group's Drug for Advanced Cutaneous Melanoma Rejected by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2626611927","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626611927?lang=en_us&edition=fundamental","pubTime":"2026-04-10 23:43","pubTimestamp":1775835830,"startTime":"0","endTime":"0","summary":"Price: 4.76, Change: -1.15, Percent Change: -19.46","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0757428866.USD","AEIS","BK4157","REPL","LU1815336091.USD","IE00B7SZL793.SGD","BK4585","IE0031619046.USD","BK4588","IE00B19Z4B17.USD","IE00B66KJ199.SGD","BK4139","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626111871","title":"Replimune issued Complete Response Letter for RP1 for advanced melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2626111871","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626111871?lang=en_us&edition=fundamental","pubTime":"2026-04-10 23:35","pubTimestamp":1775835312,"startTime":"0","endTime":"0","summary":"In a Complete Response Letter addressed to Replimune (REPL) dated April 10 posted to the site of the FDA, the agency stated: “We have completed a c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/replimune-issued-complete-response-letter-for-rp1-for-advanced-melanoma-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/replimune-issued-complete-response-letter-for-rp1-for-advanced-melanoma-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","LABU","REPL","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":189,"code":"91000000","status":"200"}]}}